1-2 of 2
Ming Qiu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor

Helen Y. Zou, Qiuhua Li, Joseph H. Lee, Maria E. Arango, Kristina Burgess, Ming Qiu, Lars D. Engstrom, Shinji Yamazaki, Max Parker, Sergei Timofeevski, Jingrong Jean Cui, Michele McTigue, Gerrit Los, Steven L. Bender, Tod Smeal, James G. Christensen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (4): 1036–1047.
https://doi.org/10.1158/1535-7163.MCT-11-0839
Published: 08 April 2012
View article titled, Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor
Open the PDF for Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor in another window
Includes: Supplementary data
Journal Articles

Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design

Ping Wei, Marlena Walls, Ming Qiu, Richard Ding, Robert H. Denlinger, Anthony Wong, Kosta Tsaparikos, Jitesh P. Jani, Natilie Hosea, Michelle Sands, Sophia Randolph, Tod Smeal
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1618–1628.
https://doi.org/10.1158/1535-7163.MCT-10-0034
Published: 09 June 2010
View article titled, Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Open the PDF for Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design in another window
Includes: Supplementary data